GSDME and neoplasm: For instance, harnessing microRNA to reactivate GSDME expression, in combination with cetuximab, has demonstrated promising results in initiating pyroptosis in malignant cells and reducing tumor size in mouse models of aggressive triple-negative breast cancer (34, 100).